JP2010513880A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513880A5
JP2010513880A5 JP2009541763A JP2009541763A JP2010513880A5 JP 2010513880 A5 JP2010513880 A5 JP 2010513880A5 JP 2009541763 A JP2009541763 A JP 2009541763A JP 2009541763 A JP2009541763 A JP 2009541763A JP 2010513880 A5 JP2010513880 A5 JP 2010513880A5
Authority
JP
Japan
Prior art keywords
pro
myocardial infarction
seq
acute coronary
coronary syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541763A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513880A (ja
JP5190067B2 (ja
Filing date
Publication date
Priority claimed from DE102006060835A external-priority patent/DE102006060835A1/de
Application filed filed Critical
Publication of JP2010513880A publication Critical patent/JP2010513880A/ja
Publication of JP2010513880A5 publication Critical patent/JP2010513880A5/ja
Application granted granted Critical
Publication of JP5190067B2 publication Critical patent/JP5190067B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541763A 2006-12-22 2007-12-22 Nt−プロbnpと組み合わせてのct−プロet−1による急性冠症候群の診断および危険性の分類 Expired - Fee Related JP5190067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006060835.6 2006-12-22
DE102006060835A DE102006060835A1 (de) 2006-12-22 2006-12-22 Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP
PCT/DE2007/002313 WO2008077396A1 (de) 2006-12-22 2007-12-22 Diagnose und risikostratifizierung des akuten koronarsyndroms mittels ct-proet-1 in kombination mit nt-probnp

Publications (3)

Publication Number Publication Date
JP2010513880A JP2010513880A (ja) 2010-04-30
JP2010513880A5 true JP2010513880A5 (enExample) 2011-11-24
JP5190067B2 JP5190067B2 (ja) 2013-04-24

Family

ID=39410311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541763A Expired - Fee Related JP5190067B2 (ja) 2006-12-22 2007-12-22 Nt−プロbnpと組み合わせてのct−プロet−1による急性冠症候群の診断および危険性の分類

Country Status (7)

Country Link
US (1) US8524463B2 (enExample)
EP (1) EP2122365B1 (enExample)
JP (1) JP5190067B2 (enExample)
CN (1) CN101646945B (enExample)
DE (1) DE102006060835A1 (enExample)
ES (1) ES2399931T3 (enExample)
WO (1) WO2008077396A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906857B2 (en) * 2005-12-01 2014-12-09 B.R.A.H.M.S. Gmbh Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
EP2016394A4 (en) 2006-04-04 2013-04-24 Singulex Inc METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE ANALYSIS OF MARKERS AND DETECTION OF MOLECULES
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
DE102007021443A1 (de) * 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1
CN102428368B (zh) * 2009-05-05 2015-04-22 B.R.A.H.M.S有限公司 患有内皮功能/功能障碍相关疾病的患者的基于血管活性激素的分层
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
US20120321595A1 (en) 2009-11-09 2012-12-20 The Brigham And Women's Hospital, Inc. Treatment of heart disease
WO2013013758A1 (en) 2011-07-28 2013-01-31 B.R.A.H.M.S. Gmbh Mid-regional pro-atrial natriuretic peptide (pro-anp) for the identification patients with atrial fibrillation with an onset of less than 48 hours ago
US20140206632A1 (en) * 2013-01-22 2014-07-24 Singulex, Inc. Endothelin in the Diagnosis of Cardiac Disease
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1327228C (zh) * 1999-01-29 2007-07-18 罗赫诊断器材股份有限公司 鉴定样品中的n-末端前bnp的方法
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
MXPA03004105A (es) 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
AU2003302132B2 (en) * 2002-11-21 2008-02-21 Inverness Medical Switzerland Gmbh Bodily fluid markers of tissue hypoxia
GB0227179D0 (en) * 2002-11-21 2002-12-24 Univ Leicester Bodily fluid markers of tissue hypoxia
DE10351238A1 (de) * 2003-11-03 2005-06-02 Roche Diagnostics Gmbh Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
ES2300681T3 (es) * 2004-07-22 2008-06-16 Brahms Aktiengesellschaft Procedimiento para el diagnostico y tratamiento de pacientes criticos con endotelina, agonistas de endotelina y antagonistas de adrenomedulina.

Similar Documents

Publication Publication Date Title
JP2010513880A5 (enExample)
JP2010507786A5 (enExample)
JP5190067B2 (ja) Nt−プロbnpと組み合わせてのct−プロet−1による急性冠症候群の診断および危険性の分類
JP2010513879A5 (enExample)
EP2084545B1 (de) Diagnose von infektionen oder entzündungserkrankungen der atemwege und lunge assoziiert mit herzinsuffizienz
JP5584473B2 (ja) Nyhai患者についての心機能不全の診断および危険性層化のためのナトリウム利尿ペプチドのインビトロ決定
JP5584695B2 (ja) Adm及びbnpのレベルを決定することによる心疾患に罹患した患者の予後診断及びリスク評価
JP2010509575A5 (enExample)
JP3783002B2 (ja) マーカーの組み合わせを用いた心臓疾患症例の予後判定
JP5320294B2 (ja) プロバソプレシンまたはその断片および部分ペプチド、特にコペプチンまたはニューロフィジンiiを使用する、急性冠動脈症候群についてのリスク層化
EP2438447B1 (en) Detection of bacterial infections in subjects suffering from dyspnea.
WO2006131529A1 (en) Use of nt-proanp and nt-probnp for diagnosing cardiac diseases
CN101126756A (zh) 心脏肌钙蛋白作为晚期冠状动脉疾病及其并发症的指示物
JP6117805B2 (ja) トロポニンおよびbnpに基づく発作のリスク患者および原因の診断
EP3279665A1 (en) Circulating esm-1 (endocan) in the assessment of atrial fibrillation
WO2009087190A1 (en) Means and methods for assessing the risk of patients presenting to emergency units based on gdf-15
JP2010511877A5 (enExample)
Chenevier-Gobeaux et al. Midregional Pro–Atrial Natriuretic Peptide for the Diagnosis of Cardiac-Related Dyspnea according to Renal Function in the Emergency Department: A Comparison with B-Type Natriuretic Peptide (BNP) and N-Terminal ProBNP
WO2008034750A1 (en) Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization
JP2010528306A (ja) 心筋梗塞の早期予測因子としてのh−fabp
Collins et al. Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease
Hammarsten et al. Copeptin: A new peptide in clinical measurement
Samsudin et al. Utility of Copeptin in acute Myocardial Infarction
HK1241025A1 (en) Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for nyha i patients
HK1196158B (en) Troponin and bnp based diagnosis of risk patients and cause of stroke